probiotics and polycistic ovary syndrome wome
- Conditions
- Polycystic Ovarian Syndrome.Sclerocystic ovary syndrome
- Registration Number
- IRCT2013081111763N11
- Lead Sponsor
- Vice Chancellor for Research, Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 72
Women with polycystic ovarian syndrome (based on Rotterdam criteria), aged 15 to 40, lack of smoking or drinking alcohol, lack of chronic heart, kidney, liver, lung or pancreatic specially endocardic diseases, thyroid disorder, small bowel syndrome, autoimmune disease, lack of allergy to probiotic capsules or placebo, not use of chemotherapy drugs (tamoxifen), corticosteroid (insulin injection, statins, diuretics) antibiotic and multivitamin mineral supplements and omega-3. Exclusion criteria: incidence of diseases mentioned above, use of multivitamin mineral supplement.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method